CCCX
Churchill Capital Corp X13.79
-0.21-1.5%
Dec 16, 4:00:01 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
717.77MP/E (TTM)
-Basic EPS (TTM)
-0.60Dividend Yield
0%Recent Filings
10-Q
Q3 FY2025 results
Churchill Capital Corp X, a blank-check SPAC, reported no revenue for Q3 2025 ended September 30, with formation and operating expenses driving a net loss wider than Q3 2024's (comparable period from inception January 4, 2024). No y/y or q/q deltas computable from disclosed figures; operating and net losses aligned without material non-operating deltas. Balance sheet shows $0 cash and $287.3M in temporary equity from 41.7M Class A shares at ~$6.88 net asset value. No debt or FCF disclosed. Still hunting a target. Business combination risks loom large.
8-K
S-4 submitted for Infleqtion merger
Churchill Capital Corp X confidentially submitted a draft S-4 registration statement to the SEC on October 29, 2025, advancing its merger with Infleqtion, announced September 8. The deal eyes Q1 2026 close, delivering over $540M gross proceeds assuming no redemptions, including $125M PIPE, to fuel quantum tech scaling. Shareholder redemptions risk cash shortfalls.
8-K
Churchill merges with quantum leader
Churchill Capital Corp X announced a merger with ColdQuanta, Inc. on September 8, 2025, valuing the target at a $1.8 billion pre-money equity stake through a two-step process involving domestication to Delaware and PIPE funding of $126.5 million at $10 per share. The deal, backed by institutional investors like Maverick Capital, aims to fuel Infleqtion's neutral-atom quantum tech for computing and sensing, targeting AI and defense markets while navigating regulatory hurdles in the U.S., U.K., and Australia. Closing hinges on shareholder votes and approvals by March 2026, but redemptions could dilute cash proceeds.
10-Q
Q2 FY2025 results
Churchill Capital Corp X, a blank-check entity, reported no revenue for Q2 FY2025 ended June 30, 2025, with operating expenses of $1.2M (derived from filing tables), up from $0.8M in Q2 2024, driven by formation and operating costs. Net loss widened to $1.5M or $(0.03) per diluted share on 51,050,000 shares, versus $1.0M or $(0.02) last year, while YTD net loss hit $2.8M or $(0.05) per share, reconciling consistently without anti-dilution effects. Cash stood at $245.6M, all from trust account investments, with no debt or capex, yielding positive operating cash flow but no free cash flow disclosed. No M&A or business combination occurred yet. A key risk: failure to complete an acquisition within 24 months could force liquidation.
8-K
New directors appointed
Churchill Capital Corp X appointed Paul Lapping and Stephen Murphy as directors effective August 1, 2025, with Lapping chairing the audit committee and Murphy joining both audit and compensation committees, replacing interim chair William Sherman who stays on the audit panel. Both bring deep SPAC and financial expertise from prior roles at firms like Salomon Brothers and Citigroup. Directors now earn $75,000 annually. These additions strengthen oversight as the SPAC hunts for a target.
BRR
ProCap Financial, Inc.
3.17-0.14
CAPN
Cayson Acquisition Corp
10.61-0.01
CCII
Cohen Circle Acquisition Corp.
10.23-0.03
CCIX
Churchill Capital Corp IX
10.57+0.00
CGCT
Cartesian Growth Corporation II
10.11+0.00
CHAC
Crane Harbor Acquisition Corp.
10.86-0.16
HCMA
HCM III Acquisition Corp.
10.08-0.01
IPCX
Inflection Point Acquisition Co
10.11+0.00
LCCC
Lakeshore Acquisition III Corp.
10.21+0.00
SVCC
Stellar V Capital Corp.
10.38+0.00